We are live on ! Find out more
New York State Common Retirement Fund

New York State Common Retirement Fund Portfolio holdings

AUM $79.3B
1-Year Est. Return 43.63%
This Fund
S&P 500
This Quarter Est. Return
+4.64%
1 Year Est. Return
+43.63%
3 Year Est. Return
+132.82%
5 Year Est. Return
+173.87%
10 Year Est. Return
+697.67%
AUM
$74.6B
AUM Growth
+$689M
Cap. Flow
-$992M
Cap. Flow %
-1.33%
Top 10 Hldgs %
32.53%
Holding
3,234
New
57
Increased
643
Reduced
1,082
Closed
59

Top Buys

Rank Stock Value
1
BA icon
Boeing
BA
+$40.8M
2
CME icon
CME Group
CME
+$28.7M
3
PRMB
Primo Brands
PRMB
+$25.4M
4
ACGL icon
Arch Capital
ACGL
+$19.3M
5
EVRG icon
Evergy
EVRG
+$18.4M

Top Sells

Rank Stock Value
1
AAPL icon
Apple
AAPL
+$81.9M
2
CNA icon
CNA Financial
CNA
+$55.4M
3
UNH icon
UnitedHealth
UNH
+$44.1M
4
AMD icon
Advanced Micro Devices
AMD
+$32.2M
5
SPOT icon
Spotify
SPOT
+$27.3M

Sector Composition

Rank Sector Weight
1 Technology 32.51%
2 Financials 13.47%
3 Consumer Discretionary 11.55%
4 Healthcare 10.78%
5 Communication Services 8.98%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TCX icon
3001
Tucows
TCX
$142M
$17.9K ﹤0.01%
1,045
VRA icon
3002
Vera Bradley
VRA
$96.4M
$17.8K ﹤0.01%
4,521
OVID icon
3003
Ovid Therapeutics
OVID
$489M
$17.7K ﹤0.01%
18,986
RDW icon
3004
Redwire
RDW
$3.13B
$17.5K ﹤0.01%
1,066
-11,600
-92% -$125K
NKTR icon
3005
Nektar Therapeutics
NKTR
$2.53B
$17.5K ﹤0.01%
1,253
STXS icon
3006
Stereotaxis
STXS
$143M
$17.3K ﹤0.01%
7,600
CTV
3007
DELISTED
Innovid Corp.
CTV
$17.3K ﹤0.01%
5,600
MGNX icon
3008
MacroGenics
MGNX
$259M
$17K ﹤0.01%
5,244
ABOS icon
3009
Acumen Pharmaceuticals
ABOS
$176M
$16.9K ﹤0.01%
9,800
BBCP icon
3010
Concrete Pumping Holdings
BBCP
$473M
$16.9K ﹤0.01%
2,531
VERU icon
3011
Veru
VERU
$44.5M
$16.8K ﹤0.01%
2,590
KYTX icon
3012
Kyverna Therapeutics
KYTX
$480M
$16.8K ﹤0.01%
4,500
MAMA icon
3013
Mama's Creations
MAMA
$822M
$16.7K ﹤0.01%
2,100
INFU icon
3014
InfuSystem Holdings
INFU
$241M
$16.5K ﹤0.01%
1,955
GALT icon
3015
Galectin Therapeutics
GALT
$315M
$16.3K ﹤0.01%
12,600
KOD icon
3016
Kodiak Sciences
KOD
$2.72B
$16.2K ﹤0.01%
1,631
NVRO
3017
DELISTED
NEVRO CORP.
NVRO
$16K ﹤0.01%
4,303
SCLX icon
3018
Scilex Holding
SCLX
$47.1M
$16K ﹤0.01%
1,071
USCB icon
3019
USCB Financial Holdings
USCB
$408M
$15.8K ﹤0.01%
889
AEVA
3020
Aeva Technologies
AEVA
$1.65B
$15.7K ﹤0.01%
3,310
TLYS icon
3021
Tilly's
TLYS
$130M
$15.7K ﹤0.01%
3,695
NRDY icon
3022
Nerdy
NRDY
$93.5M
$15.6K ﹤0.01%
9,647
CRDF icon
3023
Cardiff Oncology
CRDF
$80.1M
$15.6K ﹤0.01%
3,600
RXT icon
3024
Rackspace Technology
RXT
$1.2B
$15.6K ﹤0.01%
7,050
LSEA
3025
DELISTED
Landsea Homes
LSEA
$15K ﹤0.01%
1,767

Similar funds

New York State Common Retirement Fund's Q4 2024 Portfolio in Review

As of Q4 2024, New York State Common Retirement Fund held 3,234 positions worth $74.6B, up 0.93% from $73.9B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Trading was light in Q4 2024: portfolio turnover was 3.6%. New York State Common Retirement Fund opened 57 new positions and exited 59, leaving the 3,234-position portfolio largely intact.

By sector, the portfolio is most concentrated in Technology at 33% of assets, up from 32% a quarter earlier, followed by Financials and Consumer Discretionary.

  • New York State Common Retirement Fund's largest Q4 2024 buy was Primo Brands: 857,496 shares worth $26.4M.
  • New York State Common Retirement Fund added most to Boeing in Q4 2024, an estimated $40.8M increase.
  • New York State Common Retirement Fund's biggest Q4 2024 reduction was Apple, cutting an estimated $81.9M.
  • New York State Common Retirement Fund fully exited Primo Water Corporation in Q4 2024, selling an estimated $22.9M.
  • New York State Common Retirement Fund's ten largest holdings make up 33% of its $74.6B portfolio in Q4 2024.
  • New York State Common Retirement Fund opened 57 new positions and closed 59 in Q4 2024.
  • New York State Common Retirement Fund's portfolio value rose 0.93% quarter-over-quarter to $74.6B.

Based on New York State Common Retirement Fund's 13F filing for Q4 2024, filed 31 Jan 2025.